The Clinical Laboratory Improvement Amendments (CLIA) were established by the federal government in 1988 for the purpose of setting quality standards for all laboratory testing. A laboratory is defined as any facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. All labs meeting this definition must receive a CLIA certificate of compliance.
The following resources are available from the AAD to assist dermatologists in complying with CLIA requirements:
- CLIA FAQs: AAD practice management staff answer frequent member questions about CLIA compliance.
- AAD CLIA manual: Part of the AAD Practice Management Essentials series, this manual summarizes the federal regulation, its practice implications, and steps to gain compliance. It also contains a quality-control and quality-assurance manual, and detailed test procedures.